OKSANA MIHNUK: Open Payments
NPI 1427467570 · BROOKLYN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$322 in 15 payments from 7 companies in 2025. Trend: 2023 $395 · 2024 $483 · 2025 $322
Food & beverage: $322
| Company | Payments | Amount |
|---|---|---|
| Esperion Therapeutics, Inc. | 4 | $87 |
| Amgen Inc. | 4 | $81 |
| ABBVIE INC. | 2 | $51 |
| Novo Nordisk Inc | 2 | $48 |
| Lilly USA, LLC | 1 | $22 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $18 |
| Sumitomo Pharma America, Inc. | 1 | $14 |
Products named: NEXLETOL, OTEZLA, CREON, REPATHA, MOUNJARO, QULIPTA, XIFAXAN, GEMTESA.
Industry payments across NY — which companies pay providers there.
